Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure

Amplatzer left atrial appendage occlusion: Single center 10-year experience

(2013) Fabian Nietlispach et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation

(2013) Vivek Y. Reddy et al.   CIRCULATION

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

(2013) Ammar Majeed et al.   CIRCULATION

Warfarin Use and Stroke Risk Among Patients With Nonvalvular Atrial Fibrillation in a Large Managed Care Population

(2013) Steven B. Deitelzweig et al.   CLINICAL THERAPEUTICS

Bleeding as an Outcome Among Patients With Nonvalvular Atrial Fibrillation in a Large Managed Care Population

(2013) Steven B. Deitelzweig et al.   CLINICAL THERAPEUTICS

Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: A prospective single-center experience

(2013) KR Julian Chun et al.   HEART RHYTHM

Risk Factors for Thrombus Formation on the Amplatzer Cardiac Plug After Left Atrial Appendage Occlusion

(2013) Bjoern Plicht et al.   JACC-Cardiovascular Interventions

Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation Therapy

(2013) Marina Urena et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation

(2013) Manesh R. Patel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation

(2013) Vivek Y. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN® device in patients not taking warfarin

(2013) Felix Meincke et al.   EuroIntervention

Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding

(2012) Daniel M. Witt et al.   ARCHIVES OF INTERNAL MEDICINE

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy

(2012) Michiel Coppens et al.   EUROPEAN HEART JOURNAL

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit

(2012) S. R. Gangireddy et al.   EUROPEAN HEART JOURNAL

Safety of Percutaneous Left Atrial Appendage Closure

(2011) Vivek Y. Reddy et al.   CIRCULATION

Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials

(2011) Martin B. Leon et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial european experience

(2010) Jai-Wun Park et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients

(2009) S. SCHULMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

(2009) David R Holmes et al.   LANCET

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE